Schond L. Greenway

Schond L. Greenway has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Definium Therapeutics, Inc. and Avalo Therapeutics, Inc. The record holds 11 filings, for trades running from 10 June 2021 to 25 March 2024.

On the open market, the record shows 2 purchases worth €4,537 and 4 sales worth €118k. The net balance comes to €113k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 5 share grants.

Most recently, on 26 March 2024, the filings show a share grant worth €50k in Definium Therapeutics, Inc. The latest purchase dates back some time: it was published 1,769 days ago, on 14 December 2021. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.